John Stuelpnagel, Illumina’s senior VP, COO and GM for arrays, will shift to a part-time status in April and will give up his seat on the board of directors, although he will continue to work as an Illumina fellow, the firm said last week.
Illumina also said Senior VP and GM of Sequencing John West will resign his position as of Feb. 1, and current senior VP and CFO Christian Henry will become acting manager of sequencing.
The management changes were announced in conjunction with a reorganization of its business into two divisions, one focused on life sciences research and the other on diagnostics. The firm noted that it has already has hired two new general managers to oversee the divisions, but it has not disclosed their names.
The Seattle Biomedical Research Institute, which is establishing the Seattle Structural Genomics Center, has appointed Randy Hassler to be VP of operations and finance.
Hassler formerly was a VP of facility operations at Amgen and he has been a member of SBRI’s board of trustees for two years. He also was on the institute’s business strategy committee.
Third Wave Technologies announced the appointment of Christopher Burton as the company's senior vice president of sales and marketing. John Bellano, VP of sales, will continue to lead Third Wave's clinical sales and customer service teams in the Americas, the company announce this week.
Burton joins Third Wave from GE Healthcare, where most recently he was general manager of sales and marketing for the maternal and infant care unit. Prior to GE, Burton was a sales executive at Isotechnologies, a Hillsborough, NC-based diagnostic equipment manufacturer.